The goal of the Connors Center IGNITE Awards is to advance understanding of female-specific and sex-differentiated effects in novel therapeutics. IGNITE investigations leverage the Connors Center’s emerging First.In.Women Precision Medicine Platform to help shape the scientific focus of the study, to leverage Connors Center and FiW resources, and to assess project goals, milestones and deliverables to ensure that the emerging clinical translation remains aligned with the First.In.Women mission. IGNITE research includes basic, translational, and clinical research designed to advance therapeutic strategies using drugs, devices, and digital therapeutics.
The Connors Center is supporting three IGNITE awards throughout the 2021-2022 academic year, which provide seed funding for early stage projects to advance the understanding of female-specific and sex-differentiated effects in novel therapeutics.
We are pleased to announce that we will be featuring our second annual Special IGNITE Award focused on sex- and gender-differences in cardiac and vascular diseases for the 2022-2023 academic year. This Special IGNITE award was established through the generous gift made by the Scott Schoen and Nancy Adams Research Fund in Women’s Vascular Disease.
Connors IGNITE Awards are funded by gifts from the annual Women’s Health Luncheon and by other generous donors.